Background: Calcitonin gene-related peptide (CGRP) is expressed all through the physique and is a recognized mediator of migraine, exerting this organic impact by activation of trigeminovascular, meningeal and related neuronal pathways positioned in shut proximity to the central nervous system. Monoclonal antibodies (mAb) concentrating on the CGRP pathway are an efficient new preventive therapy for migraine, […]